Pros | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y. | ![]() 5Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y. | ||
Cons | - | ![]() Highly volatile within category. ![]() Poor track record of Recovering losses quickly. |
INDMoney rank | 7/19 | 10/19 | ||
Category,Subcateogry | Equity,Mid-Cap | Equity,Mid-Cap | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 48129 Cr | 8356 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹1000 Lumpsum ₹5000 | ||
Expense Ratio | 0.46% | 0.63% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | Nifty Midcap 150 TR INR | Nifty Midcap 150 TR INR |
No of Holdings | 69 | 39 | ||
Top 5 Holdings | Fortis Healthcare Ltd (3.59%) Ipca Laboratories Ltd (3.43%) Coromandel International Ltd (3.19%) Mphasis Ltd (3.09%) Oberoi Realty Ltd (2.73%) | Reliance Industries Ltd (9.95%) Aurobindo Pharma Ltd (8.29%) IRB Infrastructure Developers Ltd (6.91%) Container Corporation of India Ltd (6.77%) Marico Ltd (6.24%) | ||
No of Sectors | 13 | 10 | ||
Top 3 Sectors | Consumer Cyclical (16.92%) Industrial (16.8%) Basic Materials (15.39%) | Industrial (24.5%) Consumer Defensive (14.56%) Energy (12.36%) | ||
Equity % | 98.94% | 91% | ||
Debt % | - | - | ||
P/E | 28.09 | 17.64 | ||
P/B | 4.42 | 3.37 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 6.11% | 7.88% | ||
3-Month Return | -5.99% | -3.63% | ||
6-Month Return | -11.75% | -11.31% | ||
1-Year Return | 12.45% | -3.15% | ||
3-Year Return | 18.28% | 18.65% | ||
5-Year Return | 31.23% | 35.6% |
Sharpe | 0.79 | 0.7 | ||
Alpha | 0.44 | -0.78 | ||
Beta | 0.9 | 0.96 | ||
Standard Deviation | 16.45 | 18.18 | ||
Information Ratio | -0.16 | -0.23 |
Description | Kotak Emerging Equity Scheme Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Quant Mid Cap Fund Growth Option Direct Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Atul Bhole | Sanjeev Sharma,Ankit A. Pande |